Investments in the development of techniques & tools to overcome existing challenges in clinical translation of microRNA applications, strategic developments such as partnerships and mergers and acquisitions, favourable research funding scenario, and development of advanced genomic analysis techniques for quality control during miRNA manufacturing are key factors contributing to high CAGR of MicroRNA (miRNA) Market during forecast period.
Market Size – USD 171.4 Million in 2018, Market Growth - CAGR of 11.6%, Market Trends – Product launches and research for MicroRNA (miRNA) market.
According to the current analysis of Reports and Data, the global MicroRNA (miRNA) market was valued at USD 171.4 Million in 2018 and is expected to reach USD 415.1 Million by year 2026, at a CAGR of 11.6% percent. The study covers different types of products which can boost up the market and the technology and the services available in this market for gene silencing. Gene silencing via RNA interference (RNAi) is rapidly evolving as a personalized approach to cancer treatment. The effector molecule i.e. MicroRNA (miRNA)—can be used to “switch off” specific cancer genes. Quite recently, they have been examined as innovative classes of therapeutic agents for healing a broad range of syndromes including cancers and infections.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-microrna-mirna-market
Further key findings from the report suggest:
- miRNA Market is fastest growing at a CAGR of 6% in Asia Pacific followed by Europe respectively. High progress in genomics and upcoming M&A deals are the key factors to propel the market growth during forecast period across these
- qRT-PCR segment type has the largest market share of 37.3%
- Microarray Analysis Tools are also one of the key technologies employed in the functional studies of these molecules which drive the market for miRNA with a CAGR of 11.2%
- Europe accounts for the second largest market share of the global miRNA market at 29.2% due to huge approval of fund through European Union
- The Pharmaceutical and Biotech Companies end use segment is expected to register largest CAGR of 11.8% during 2019-2026 due to rapid usage of research tools
- Key participants include Agilent Technologies, Exigon, Merck KGA, Illumina, Inc., NanoString Technologies, Inc., and Thermo Fischer Scientific Inc
Segments covered in the report:
For the purpose of the study, this Reports and Data has segmented the Global MicroRNA (miRNA) Market on the basis of product type, research tools and services type, application, end user and the regional outlook:
Global MicroRNA (miRNA) Key Market Segments:
Product Type: (Revenue, USD Million; 2016–2026)
- Instruments
- Kits, Reagents & Consumables
- Isolation & Purification
- Quantification & Detection
- Functional Analysis
- Others
Research Tools and Services: (Revenue, USD Million; 2016–2026)
- Tools
- qRT-PCR
- Biomarkers
- Next Gen Sequencing (NGS)
- Microarray Analysis Tools
- Functional Analysis Tools
- Extraction Tools
- Others
- Services
- miRNA cDNA Synthesis
- Quantification Services
- Microarray Services
- Sequencing Services
- Functional Studies Services
- Others
Application: (Revenue, USD Million; 2016–2026)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
End Use: (Revenue, USD Million; 2016–2026)
- Academic & Research Institutes
- Biopharmaceutical Companies
- CRO
- Diagnostic Centres
Regional Outlook: (Revenue, USD Million; 2016–2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Spain
- France
- Italy
- Russia
- Asia Pacific
- Japan
- China
- India
- Singapore
- Australia and New Zealand
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LAMEA
- Middle East and Africa (MEA)
- Rest of MEA
Request
For Free PDF Sample of This Research Report at:
No comments:
Post a Comment